CA
NZ
UK
AU
IND
US
Hudson Vegas Investment SPV, LLC, together with Hudson Vegas Investment Manager, LLC and Daniel Straus, filed a Form 4 on August 12, 2026, disclosing the sale of all directly held Class A Common Stock of P3 Health Partners Inc. (NASDAQ:PIII) on August 10, 2026.
A Form 4 filed on August 12, 2026 discloses that Tan Anthony Ping Yeow, Chief Executive Officer and Director of Grab Holdings Ltd (NASDAQ:GRAB), sold 400,000 Class A Ordinary Shares on August 10, 2026 under a pre-established Rule 10b5-1(c) trading plan.
Damian Andrew Ribar, Executive Vice President and Chief Operating Officer of Casella Waste Systems Inc, reported the acquisition of 25,000 employee stock options on August 11, 2026, in a statement of changes in beneficial ownership filed with the SEC on August 12, 2026.
Travis Michael Witteveen, Head of Products and Portfolio at Gen Digital Inc. (NASDAQ:GEN), filed a Form 4 on August 12, 2026, reporting the sale of 30,000 shares of common stock on August 10, 2026.
Ben Sousa, Chief Information Officer of ICU Medical Inc/DE (NASDAQ:ICUI), filed a Form 4 on August 12, 2026, reporting the sale of 2,250 shares of common stock on that same date.
Robert C. Ritchie, Chief Executive Officer and Director of American Integrity Insurance Group, Inc., filed a Form 4 on August 12, 2026, disclosing the sale of 5,800 shares of common stock on August 10, 2026.
Director Huda Y. Zoghbi filed a Form 4 with the SEC on August 12, 2026, disclosing transactions in Regeneron Pharmaceuticals, Inc. common stock dated August 10, 2026, including a stock option exercise and a same-day sale of shares.
A Form 4 filed with the SEC on August 12, 2026, discloses that Robert Z. Hensley, a director of Community Healthcare Trust Inc (NYSE:CHCT), purchased 8,000 shares of common stock on August 11, 2026.
Director Jennifer S. Grafton filed a Form 4 with the SEC on August 12, 2026, disclosing a stock option exercise and subsequent sale of common stock in Dakota Gold Corp. on August 10, 2026.
Kathryn Guarini, a director at Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on August 12, 2026, disclosing the exercise of 400 stock options and the same-day sale of 400 shares of common stock on August 10, 2026, under a pre-established Rule 10b5-1 trading …
Please wait processing your request...